FindTrial
Sign In

Detection of Prostate cancer using MRI

Diagnostic performance of diffusion weighted imaging for prostate cancer detection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053705
Enrollment
46
Registered
2023-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C61- Malignant neoplasm of prostate

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants who are above 40 years of age and referred for prostate MRI with confirmed prostate cancer.

Exclusion criteria

Exclusion criteria: patients post-surgical surgery of prostate cancer. patients with prostate cancer and undergone radiation therapy or chemotherapy.

Design outcomes

Primary

MeasureTime frame
b value for DWI for scanning of prostate cancer. Timepoint: 1 year 4 months—

Secondary

MeasureTime frame
ADC cut-off value for prostate tumors.Timepoint: 1 year 4 month—

Countries

India

Contacts

Public ContactDr Winniecia Dkhar

Manipal college of health professions, Manipal Academy of higher education, Manipal

winniecia.dkhar@manipal.edu8095372184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026